Allscripts (MDRX) Misses Street's Q1 View
More News related to MDRX
- Allscripts Supports Landmark Medicare Electronic Prescribing Provisions
- eRx Network Joins National ePrescribing Patient Safety Initiative as Connectivity Partner
- National ePrescribing Patient Safety Initiative Supports Senate's Call for Physicians to Adopt Electronic Prescribing, Improving Patient Safety
- Cramer Sees Allscripts (MDRX) Moving 44% Higher
- Pre-Open Movers 7/2: Family Dollar (FDO) Jumps On Strong Results; Circuit City (CC) Lower After Blockbuster Walks
Allscripts (Nasdaq: MDRX) reports Q1 EPS of $0.09, 2 cents lower than the analyst estimate of $0.11. Revenues for the quarter were $72.1 million, versus the consensus of $74.69 million.
Related Categories
EarningsStocks Mentioned
-0.10Related Entities
Sign up for StreetInsider Free!
Recieve full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
